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Abstract
Although previous studies have demonstrated that plasma levels of the proinflammatory cytokine tumor necrosis factor-K
(TNF-K) increase during early sepsis, the precise mechanism responsible for its upregulation remains to be elucidated. Since
recent studies have shown that the gut is an important source of norepinephrine (NE) release during early sepsis and
enterectomy prior to the onset of sepsis attenuates TNF-K production, we hypothesized that gut-derived NE plays a major
role in upregulating TNF-K via the activation of K2-adrenoceptors on Kupffer cells. To confirm that NE increases TNF-K
synthesis and release, Kupffer cells were isolated from normal rats and incubated with NE (20 or 50 nM) or another K2-
adrenergic agonist clonidine (50 nM) without addition of Escherichia coli endotoxin. Supernatant levels of TNF-K were then
measured. In additional animals, intraportal infusion of NE (20 WM) with or without the specific K2-adrenergic antagonist
yohimbine (1 mM) at a rate of 13 Wl/min was carried out for 2 h. Plasma and Kupffer cell levels of TNF-K were assayed
thereafter. Moreover, the effects of NE and yohimbine on TNF-K production was further examined using an isolated
perfused liver preparation. The results indicate that both NE and clonidine increased TNF-K release by approximately 4^7-
fold in the isolated cultured Kupffer cells. Similarly, intraportal infusion of NE in vivo or in isolated livers increased TNF-K
synthesis and release which was inhibited by co-infusion of yohimbine. Furthermore, the increased cellular levels of TNF-K
in Kupffer cells after in vivo administration of NE was also blocked by yohimbine. These results, taken together, suggest that
gut-derived NE upregulates TNF-K production in Kupffer cells through an K2-adrenergic pathway, which appears to be
responsible at least in part for the increased levels of circulating TNF-K observed during early sepsis as well as other
pathophysiologic conditions such as trauma, hemorrhagic shock, or gut ischemia/reperfusion. ß 2001 Elsevier Science B.V.
All rights reserved.
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1. Introduction
Studies have indicated that proin£ammatory medi-
ators play a critical role in the hemodynamic, meta-
bolic, and immunologic response to sepsis [1,2]. Fur-
thermore, it has been suggested that hepatocellular
dysfunction observed early after the onset of sepsis
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may be a consequence of upregulated proin£amma-
tory cytokines, such as tumor necrosis factor-K
(TNF-K) [3,4]. In this regard, we have previously
shown that circulating levels of TNF-K increased sig-
ni¢cantly during sepsis [5]. Moreover, upregulation
of TNF-K gene expression in Kup¡er cells occurred
even earlier than the onset of hepatocellular dysfunc-
tion during sepsis [6,7]. Although endotoxin has been
proposed to be a major mediator responsible for up-
regulating TNF-K following endotoxemia or under in
vitro conditions [8], it is possible that other media-
tors may also play an important role in increasing
TNF-K production during sepsis. This is supported
by the ¢ndings that macrophages isolated from en-
dotoxin-tolerant mice exhibited a marked spontane-
ous release of TNF-K after the onset of sepsis [9]. It
is also known that peripheral sympathetic nerve ac-
tivity increases during sepsis, resulting in an elevation
in plasma levels of norepinephrine (NE). Studies
from our laboratory [10] as well as by Kovarik et
al. [11] indicate that systemic levels of NE increased
signi¢cantly after the onset of sepsis as produced by
cecal ligation and puncture (CLP). To this end, our
recent data have shown that although both systemic
and portal levels of NE increased during the early
stage of sepsis, the levels of NE in portal blood were
signi¢cantly higher than in systemic blood [12]. In
addition, enterectomy prior to the onset of sepsis
markedly reduced circulating levels of NE [12].
This ¢nding would suggest that the gut is the major
source of NE release during sepsis. Moreover, Speng-
ler et al. reported that NE increased endotoxin-
stimulated TNF-K production by isolated peritoneal
macrophages [13]. Since Kup¡er cells are the major
source of proin£ammatory cytokine TNF-K release
[14] and since the gut plays an important role in NE
release during sepsis, we hypothesized that gut-de-
rived NE upregulates TNF-K through the activation
of Kup¡er cell K2-adrenoceptors. To study this, in-
traportal infusion of NE and the e¡ect of NE on
TNF-K release were examined with or without co-
administration of a speci¢c K2-adrenergic antagonist.
2. Material and methods
Male Sprague^Dawley rats (275^325 g) were used
in this study. The animals were fasted overnight be-
fore the experiment, but water allowed ad libitum.
The rats were anesthetized with intraperitoneal ad-
ministration of pentobarbital sodium (50 mg/kg body
wt.) in all surgical procedures. The animal studies
described below were performed in accordance with
the National Institutes of Health guidelines for the
use of experimental animals. This project was ap-
proved by the Institutional Animal Care and Use
Committees of the University of Alabama at Bir-
mingham.
2.1. Isolation of Kup¡er cells
Kup¡er cells were isolated from rats as previously
described elsewhere [15] with some modi¢cations.
Brie£y, the inferior vena cava was cannulated follow-
ing a midline incision, and the portal vein was sev-
ered. The liver was immediately perfused in situ with
V60 ml of Hanks balanced salt solution (HBSS;
without Ca2 and Mg2), at 37‡C at a rate of 15
ml/min. This was followed by perfusion of 100 ml
of HBSS containing 0.02% collagenase (Worthing-
ton; Type II, 274 U/mg), 0.02% trypsin inhibitor
(Sigma) and 0.5% 100 mM CaCl2 solution at the
same perfusion rate. The liver was then removed en
bloc, rinsed withV25 ml of HBSS, minced in a Petri
dish containing HBSS with collagenase, and incu-
bated for 20 min at 37‡C to further dissociate the
cells. The cell suspension was then passed through
a sterile 150-mesh stainless steel screen into cold Dul-
becco modi¢ed Eagle medium (DMEM) containing
10% heat-inactivated fetal bovine serum (¢nal vol-
ume 125 ml) and centrifuged (700 rpm for 2 min at
4‡C) to sediment hepatocytes. The remaining cells in
the supernatant were collected by centrifugation
(1800 rpm for 15 min at 4‡C). The supernatant was
discarded and the cell pellets were resuspended in 60
ml DMEM. Using a transfer pipette, 5 ml of cells
was gently laid over 4 ml 16% metrizamide (Accurate
Chemical and Scienti¢c Co). The Kup¡er cell layer
was found at the interface of the metrizamide and
the media following centrifugation (3200 rpm for 45
min at 4‡C). The cells were further washed with 25
ml DMEM. Cell viability was determined by trypan
blue exclusion, which was more than 95%. Approx-
imately 90% nonparenchymal liver cells ingested In-
dia ink and more than 80% of those cells were pos-
itive on peroxidase staining [16]. With the further
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puri¢cation procedure, the purity of Kup¡er cells
was found to be at least 90% with a yield of Kup¡er
cells at 5^10U106/liver. Further puri¢cation of
Kup¡er cells was performed by adhesion as de-
scribed below.
2.2. Stimulation of the isolated Kup¡er cells with
K2-adrenergic agonists
The isolated Kup¡er cells from normal animals
were cultured in Click’s medium (Gibco) with
0.14% sodium bicarbonate, 10% heat inactivated fe-
tal calf serum and 0.1% gentamycin at the concen-
tration of 106 cells/ml. Kup¡er cells were allowed to
adhere on the bottom of the plastic culture dish for
3 h, and unattached cells were removed by gentle
washing. Kup¡er cells were then cultured in Click’s
medium with either K2-adrenergic agonists NE (20 or
50 nM) or clonidine (50 nM) for a period of 4 h (i.e.,
NE or CD was present in the culture medium for
4 h). The supernatant was then collected and TNF-K
levels were measured by enzyme-linked immunosorb-
ent assay (ELISA). It should be noted that other
stimulants such as endotoxin were not added to the
culture system. Every e¡ort was made to minimize
any contamination of endotoxin during Kup¡er cell
isolation and culture.
2.3. Intraportal infusion of NE
Following anesthesia with pentobarbital sodium, a
3-cm midline incision was performed. The small in-
testine was exposed and a branch of the superior
mesenteric vein was cannulated with a PE-10 cathe-
ter. It should be noted that this procedure did not
cause any apparent gut ischemia. NE solution at a
concentration of 20 WM (in normal saline) was in-
fused into the portal vein at a rate of 13 Wl/min for
2 h using a Harvard pump. Since portal blood £ow is
V13 ml/min/liver [17], the above rate of NE infusion
would be expected to increase the portal NE level to
20 nM, which is similar to that observed during sep-
sis [10]. Ascorbate (0.1%) was added to the NE so-
lution to prevent it from breaking down by oxida-
tion. In addition to NE and vehicle (0.1% ascorbate
in normal saline) groups, a third group of rats re-
ceived NE and an K2-adrenergic antagonist, yohim-
bine (YHB). YHB (1 mM solution at 13 Wl/min) was
¢rst infused into the portal vein for 15 min followed
by infusion of 20 WM NE in combination with 1 mM
YHB for 2 h at an infusion rate of 13 Wl/min. After
the completion of the infusion of NE or NE with
YHB, blood samples were collected by cardiac punc-
ture and Kup¡er cells were isolated as described
above.
2.4. Isolated perfused liver preparation
The isolated perfused rat liver preparation [18,19]
has been recently used in our laboratory [12]. Brie£y,
rats were anesthetized with methoxy£urane inhala-
tion and a midline incision along the length of the
abdomen was made to expose the liver. The common
bile duct was isolated and cannulated with PE-10
tubing for the collection and determination of bile
production throughout the experiment. The portal
vein was cannulated with a 16-gauge silicon catheter
and perfused in situ ¢rst with 3-ml normal saline
containing 20 U/ml heparin and then with Krebs^
Henseleit bu¡er as described below. A 12-gauge sil-
icone tube was cannulated into the inferior vena cava
(the region above the renal vein) toward the liver
direction for collecting perfusion e¥uent. The dia-
phragm is incised and the vena cava was ligated
suprahepatically. A blood pressure analyzer (Micro-
Med, Louisville, KY) was connected to the catheter
cannulated into the portal vein to monitor perfusion
pressure. Following the saline perfusion to clean the
blood, the liver was perfused with Krebs^Henseleit
bu¡er which was gassed with 95% O2 and 5% CO2.
Glucose (0.1%) and 0.5% bovine serum albumin
(fraction V) were added to provide an energy source
and nutrition. The temperature (37‡C), pH (7.3^7.4),
pO2 (v500 mmHg) of perfusate, and perfusion pres-
sure (14 cm H2O) were maintained during the entire
perfusion. The liver was perfused with Krebs-Hense-
leit bu¡er at a rate of 36 ml/min for 30 min without
recirculating the bu¡er. Then, 200 ml fresh Krebs^
Henseleit bu¡er was recirculated in the liver for addi-
tional 60 min. The e¥uent was collected every 15
min. Approximately 0.5 ml e¥uent was collected at
each time point for the determination of TNF-K.
Animals were divided into three groups, including
(1) NE (20 nM); (2) NE (20 nM) in combination
with YHB (1 WM); and (3) the vehicle group (normal
saline instead of NE or YHB). It should be noted
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that NE and/or YHB were added to the reservoir to
achieve constant concentration of these agents
throughout the experiment period.
2.5. Determination of TNF-K
Following the collection of blood samples, serum
was separated by centrifugation at 2500 rpm for 15
min at 4‡C. Serum and supernatant from Kup¡er
cells cultures as well as the e¥uent from the isolated
perfused liver preparation were divided into aliquots,
and stored at 370‡C until assayed. In order to de-
termine cellular TNF-K levels, 0.25 ml (i.e., 5U106
cells) of Kup¡er cell suspension was sonicated to
disrupt the cells and centrifuged at 14 000 rpm for
15 min at 4‡C to sediment the cell debits. The super-
natant was then collected and used for TNF-K assay.
TNF-K levels were quanti¢ed using an ELISA assay
kit speci¢c for rat TNF-K (Pharmingen, San Diego,
CA). The assay was carried out according to the
instructions provided by the manufacturer. The
same assay was used for the determination of
TNF-K in e¥uent, culture supernatant, cells and se-
rum.
2.6. Determination of endotoxin levels
Levels of endotoxin in e¥uent and plasma were
measured using a limulus amebocyte lysate assay
(LAL) kit (Associates of Cape Cod, Falmouth,
MA) according to the manufacturer’s instruction.
Brie£y, 50 Wl of sample was diluted 1:10 in LAL
reagent water. Endotoxin (Escherichia coli
0113:H10, provided by the manufacturer) was used
as the standard. Both standard and samples were
heated for 15 min at 75‡C and were then added to
a 96-well plate. Fifty Wl of pyrochrome was added to
each well, mixed on a plate shaker for 30 s, and
incubated for 35 min at 37‡C followed by the addi-
tion of 25 Wl 50% acetic acid to stop the reaction.
The optical density was determined at 405 nm using
a spectrophotometer. The levels of endotoxin were
then calculated and expressed as EU/ml.
2.7. Statistical analysis
All data are expressed as means þ S.E.M. and
compared by one-way analysis of variance (AN-
OVA) and Tukey’s test. Di¡erences in values were
considered signi¢cant if P90.05.
3. Results
3.1. E¡ects of NE and clonidine on TNF-K production
in Kup¡er cell culture
As shown in Fig. 1, incubation of the isolated
Kup¡er cells from normal animals with NE at a
concentration of 20 or 50 nM for a period of 4 h
increased supernatant TNF-K levels by 497% and
411%, respectively. Similarly, incubation of the
Kup¡er cells with 50 nM clonidine enhanced TNF-
K production by 677% (Fig. 1). It should be noted
that the cells were incubated with NE or clonidine in
the absence of endotoxin or other stimulants.
3.2. E¡ects of NE and YHB on serum and Kup¡er
cells levels of TNF-K after intraportal infusion
As indicated in Fig. 2, serum levels of TNF-K in-
creased from 21.5 þ 15.9 pg/ml to 286.9 þ 110.3 pg/ml
after the completion of the intraportal infusion of
Fig. 1. Alterations in TNF-K levels in Kup¡er cell culture
supernatant. Kup¡er cells were cultured in Click’s medium with
either K2-adrenergic agonists NE (20 or 50 nM) or clonidine
(CD, 50 nM) for a period of 4 h. The supernatant was then
collected and TNF-K levels were measured by enzyme-linked
immunosorbent assay (ELISA). Other stimulants such as endo-
toxin were not added to the culture system. Every e¡ort was
made to minimize any contamination of endotoxin during
Kup¡er cell isolation and culture. Data are presented as
mean þ S.E.M. (n = 4) and compared by one-way ANOVA and
Tukey’s test. *P6 0.05 vs. non-stimulation.
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NE (P6 0.05). When the K2-adrenergic antagonist
YHB was co-administered with NE, TNF-K produc-
tion was signi¢cantly attenuated to a level which was
not signi¢cantly di¡erent from vehicle-infused ani-
mals (Fig. 2). Similarly, cellular TNF-K levels in
Kup¡er cells increased by 54.3% (P6 0.05) after in-
traportal infusion of NE (Fig. 3). However, co-ad-
ministration of NE with YHB prevented the eleva-
tion of Kup¡er cell TNF-K levels (Fig. 3).
3.3. E¡ects of NE and YHB on TNF-K release in
isolated perfused liver preparation
The results in Fig. 4 indicate that the signi¢cant
increase in TNF-K levels in the e¥uent occurred at
45 min (by 4.6-fold) during NE perfusion and per-
sisted at 75 and 90 min of the infusion (by 6.2- and
5.1-fold). In contrast, co-administration of YHB
with NE completely prevented the NE-induced in-
crease in TNF-K release (Fig. 4), suggesting that
NE induced upregulation of TNF-K is K2-adrenocep-
tor-mediated. Although YHB appears to reduce
TNF-K levels in e¥uent between 75^90 min after
Fig. 2. Alterations in serum levels of TNF-K after administra-
tion of NE, NE combined with YHB or vehicle. NE solution at
a concentration of 20 WM (in normal saline) was infused into
the portal vein at a rate of 13 Wl/min for 2 h to produce a por-
tal NE level of 20 nM. Ascorbate (0.1%) was added to the NE
solution to prevent it from breaking down by oxidation. In ad-
dition to NE and vehicle (0.1% ascorbate in normal saline)
groups, a third group of rats received NE and an K2-adrenergic
antagonist, yohimbine (YHB). YHB (1 mM solution at 13 Wl/
min) was ¢rst infused into the portal vein for 15 min followed
by infusion of 20 WM NE in combination with 1 mM YHB for
2 h at an infusion rate of 13 Wl/min. After the completion of
the infusion of NE or NE with YHB, blood samples were col-
lected by cardiac puncture and serum was separated for TNF-K
assay by ELISA. Data are presented as mean þ S.E.M. (n = 5^6)
and compared by one-way ANOVA and Tukey’s test. *P6 0.05
vs. vehicle; #P6 0.05 vs. NE.
Fig. 3. Alterations in TNF-K levels in Kup¡er cells after admin-
istration of NE, NE combined with YHB or vehicle. See the
legend for Fig. 2 for further details. Data are presented as
mean þ S.E.M. (n = 5^6) and compared by one-way ANOVA
and Tukey’s test. *P6 0.05 vs. vehicle; #P6 0.05 vs. NE.
Fig. 4. Alterations in TNF-K production in the e¥uent of the
isolated liver preparation after perfusion with NE, NE com-
bined with YHB or vehicle. Following the isolation, the liver
was perfused with Krebs^Henseleit bu¡er at a rate of 36 ml/
min for 30 min without recirculating the bu¡er. 200 ml fresh
Krebs^Henseleit bu¡er was then recirculated in the liver for an
additional 60 min. The e¥uent was collected every 15 min. Ani-
mals were divided into three groups, including (1) NE (20 nM);
(2) NE (20 nM) in combination with YHB (1 WM); and (3) the
vehicle group (normal saline instead of NE or YHB). Data are
presented as mean þ S.E.M. (n = 4^5) and compared by one-way
ANOVA and Tukey’s test. *P6 0.05 vs. vehicle; #P6 0.05 vs.
NE.
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the initiation of perfusion, there was no statistical
di¡erence in TNF-K levels between NE plus YHB-
perfused livers and vehicle-perfused livers.
3.4. Changes in endotoxin
Endotoxin levels of sterile saline were not detect-
able. In the blood samples collected from the normal
animals with intraportal infusion of vehicle, endotox-
in levels were 0.13 þ 0.03 EU/ml (n = 4, mean þ S.E.),
which are not signi¢cantly di¡erent (P = 0.11) from
the unmanipulated rats (0.07 þ 0.01 EU/ml), as re-
ported previously by us [5]. Intraportal administra-
tion of NE or NE plus YHB did not signi¢cantly
alter plasma levels of endotoxin (data not shown).
Endotoxin levels in the e¥uent were 0.53 þ 0.04
EU/ml. Although this is statistically higher than plas-
ma levels of endotoxin as indicated above, such a
moderate increase only represents less than 10% of
plasma endotoxin levels observed during polymicro-
bial sepsis (average 5.69 EU/ml) [5]. Thus, the e¡ects
of NE on TNF-K production does not appear to be
due to signi¢cant elevation of endotoxin. Although
the precise source of this modest level of endotoxin
in the perfusate remains unknown, the possible con-
tamination during the 90-min perfusion period may
be responsible for the low level of endotoxin.
4. Discussion
Although our knowledge of the pathophysiology
of sepsis and in£ammation has been prodigiously
expanded in the past decade and many host media-
tors have been identi¢ed, a comprehensive under-
standing of the role of various proin£ammatory me-
diators and their interactions during sepsis remains
elusive. Proin£ammatory mediators such as TNF-K
and neurotransmitters such as NE are elevated fol-
lowing the onset of sepsis [5,8,10,11]. Thus, under-
standing the relationship between neurotransmitters
and proin£ammatory mediators should lead to fur-
ther insights into the mechanism responsible for cel-
lular dysfunction during sepsis.
It has been suggested that the gut is an important
source of endogenous NE. The extensive contribu-
tion of mesenteric organs (primarily the gut) to total
body NE production was not recognized until 1995
when studies of regional NE kinetics were conducted
by sampling blood from the portal venous site
[20,21]. Studies by Eisenhofer et al. have shown high-
er concentrations of NE in portal venous than arte-
rial blood, suggesting substantial production of NE
by mesenteric organs [21,22]. Studies have demon-
strated that the gut produces about one-half of the
NE formed in the body under normal conditions
[20,22]. In contrast, the contribution of the brain to
total body NE turnover is only 3^9% [22]. Unlike
NE, more than 90% of the epinephrine formed in
the body is produced within the adrenals [20,22]
and splanchnic tissues do not release epinephrine
[23]. Studies from our laboratory [10] as well as
others [11] indicate that systemic levels of NE in-
crease signi¢cantly during sepsis. We have also
shown that portal levels of NE are signi¢cantly high-
er than those in systemic blood during early sepsis
[12]. In addition, prior enterectomy markedly reduces
plasma levels of NE at 2 h after the onset of sepsis
[12]. Thus, the gut appears to be the major source of
NE during sepsis. The ¢ndings that plasma levels of
TNF-K increase as early as 1.5 h after the onset of
sepsis [6] while NE levels increase 30 min or even
earlier after the onset of sepsis [10] suggest that NE
may induce TNF-K production under such condi-
tions. In this regard, our recent results have indicated
that enterectomy prior to the onset of sepsis pre-
vented the increase in circulatory levels of NE and
TNF-K [12]. Similarly, studies have shown that NE
production and release are found to be signi¢cantly
correlated with the spontaneous secretion of TNF-K
by alveolar macrophages [24]. Due to the intimate
connection of the gut and liver via portal circulation,
Kup¡er cells are positioned to receive constant ex-
posure to gut-derived mediators such as NE, which
in£uence Kup¡er cells. In the present study, we
tested the hypothesis that gut-derived NE per se
plays an important role in increasing TNF-K produc-
tion in Kup¡er cells via the activation of K2-adreno-
ceptors. We focused our attention on Kup¡er cells
instead of other macrophage populations since
Kup¡er cells, which constitute 80^90% of the ¢xed
tissue macrophages in the reticuloendothelial system,
have been shown to be activated to express TNF-K
mRNA [6,25,26] and are considered a major source
of in£ammatory cytokine release [6,14,27]. More-
over, in the liver, Kup¡er cells are the only cell pop-
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ulation in the hepatic sinusoids of lipopolysaccha-
ride-perfused liver to express TNF-K mRNA [28].
The isolated Kup¡er cells were used to determine
whether K2-adrenergic agonists NE and clonidine in-
crease TNF-K production in the absence of endotox-
in stimulation. Our results indicate that NE at the
concentration similar to that observed during sepsis
(20 nM) [10] signi¢cantly increased supernatant levels
of TNF-K after a 4-h incubation. Similarly, 50 nM
NE or clonidine also upregulated TNF-K under in
vitro culture conditions. In addition, intraportal ad-
ministration of NE signi¢cantly increased serum and
Kup¡er cell levels of TNF-K, indicating that NE up-
regulates TNF-K not only under in vitro condition
but also under in vivo condition. Co-infusion of the
speci¢c K2-adrenergic antagonist yohimbine pre-
vented the increase of TNF-K in plasma and Kup¡er
cells. To further con¢rm this ¢nding, an isolated per-
fused liver preparation was used. The results clearly
indicate that perfusion of the isolated liver with 20
nM NE increased TNF-K production, which was
completely blocked by co-infusion with yohimbine.
These results, taken together, suggest that increased
levels of NE (similar to that observed during sepsis)
induce TNF-K production in the liver (by Kup¡er
cells) via an K2-adrenoceptor-mediated mechanism.
It could be argued that the trace amount of endotox-
in observed in the e¥uent (average 0.53 EU/ml) may
contribute to TNF-K release from the isolated per-
fused livers following the stimulation with NE. How-
ever, our ¢ndings that intraportal administration of
NE did not signi¢cantly alter plasma levels of endo-
toxin, but markedly increased TNF-K production
suggest that the role of endotoxin in NE-induced
TNF-K release by rat Kup¡er cells, if any, is mini-
mal.
It should be noted that the modest increase in
Kup¡er cell TNF-K levels after intraportal infusion
of NE (from 16.7 þ 2.9 to 25.9 þ 1.9 pg/106 cells, Fig.
3) appears to be due to the possibility that TNF-K
storage capacity of Kup¡er cells is limited and that
an excess amount of TNF-K produced by this cell
population is released to the circulation. This is con-
¢rmed by the ¢ndings that while Kup¡er cell TNF-K
increased by 54%, circulating levels of TNF-K were
elevated by more than 12-fold following intraportal
administration of NE (Figs. 2 and 3). The increased
TNF-K release by Kup¡er cells following NE admin-
istration is associated with pathophysiologic conse-
quences. In this regard, we have recently demon-
strated that infusion of the isolated perfused liver
preparation with 20 nM NE, which signi¢cantly in-
creased e¥uent levels of TNF-K (Fig. 4), reduced the
hepatic clearance capacity of indocyanine green
(ICG, a measure of hepatocellular function [4])
[12]. Similarly, our preliminary results indicate that
intraportal administration of NE signi¢cantly re-
duced in vivo ICG clearance without altering circu-
lating levels of alanine aminotransferase (ALT). We
have previously shown that ICG clearance is more
sensitive to detect hepatocellular dysfunction than
the elevation of circulating liver enzymes such as
ALT [4,29]. In addition, it is possible that the spleen
may also contribute to the elevated levels of circulat-
ing TNF-K following NE administration or during
sepsis. Although Kup¡er cells in the liver appear to
be the major source of proin£ammatory cytokine
release in sepsis [14], it remains to be determined to
what degree does the spleen contribute to TNF-K
levels observed following intraportal administration
of NE.
It could be argued that TNF-K released by the
isolated perfused liver preparation may also come
from hepatic endothelial cells. Although we have
not performed experiments to assess whether prior
depletion of Kup¡er cells reduces TNF-K release in
the isolated perfused liver preparation, our prelimi-
nary results suggest that Kup¡er cells are responsible
for producing proin£ammatory cytokine TNF-K dur-
ing the early stage of sepsis. Brie£y, the number of
Kup¡er cells in male adult rats was reduced in vivo
by intravenous injection of gadolinium chloride
(GdCl3, 10 mg/kg) 48 h prior to cecal ligation and
puncture (CLP, i.e., an animal model of polymicro-
bial sepsis). The results indicate that the circulating
levels of TNF-K increased from nondetectible in
sham-operated animals to 148.9 þ 30.3 pg/ml at 5 h
after CLP (i.e., an early stage of sepsis). Pre-admin-
istration of GdCl3, however, signi¢cantly attenuated
the increase in circulating TNF-K levels to 35.1 þ 20.2
pg/ml (P6 0.05, n = 5/group). Moreover, both IL-1L
and IL-6 levels increased signi¢cantly at 5 h after
CLP in Kup¡er cell-intact animals and Kup¡er cell
reduction by GdCl3 signi¢cantly reduced circulating
levels of IL-1L and IL-6 [14]. These results, taken
together, indicate that Kup¡er cells are indeed re-
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sponsible for producing proin£ammatory cytokines
during the early stage of sepsis. Although we have
not assessed whether hepatic endothelial cells play
any role in contributing to NE-stimulated TNF-K
production, the above results suggest that Kup¡er
cells are most likely to be responsible for NE-induced
TNF-K release from the isolated perfused liver prep-
aration.
Although the exact signal transduction mechanism
responsible for the upregulatory e¡ect of activation
of K2-adrenoceptors on TNF-K production remains
unknown, stimulation of K2-adrenoceptors is associ-
ated with the inhibition of adenylate cyclase via the
inhibitory GTP-binding protein (Gi) subunit and
subsequent suppression of intracellular cAMP [30].
It appears that stimulation of K2-adrenoceptors en-
hances TNF-K production through the reduction of
cAMP [31]. In this regard, our preliminary results
indicate that Kup¡er cell cAMP levels decrease sig-
ni¢cantly at 2 h after CLP, which was associated
with an increase in Kup¡er cell K2-adrenoceptor
binding capacity and a⁄nity. The presence of K2-
adrenoceptors on macrophages has been con¢rmed
by receptor binding assays [13,32] and in situ hybrid-
ization [33]. It should be noted that K2-adrenoceptors
appear to function in an opposite manner to L2-adre-
noceptors on macrophages and do so at pathophy-
siologic concentrations (V1038 M) [13,34]. Our pre-
vious ¢ndings indicate that circulating NE reaches
levels as high as 2U1038 M (20 nM) during sepsis
[10]. Thus, it appears that the levels of NE encoun-
tered during sepsis would most likely stimulate K2-
adrenoceptors on Kup¡er cells. In contrast, the in-
crease in intracellular cAMP levels following stimu-
lation of Kup¡er cell L2-adrenoceptors by epineph-
rine (epinephrine has up to 100-fold higher selectivity
for L2-adrenoceptors than NE [30] or inhibition of
phosphodiesterase by pentoxifylline downregulates
TNF-K gene expression and reduces its release [35^
37]. It should be pointed out that incubation of
splenic macrophages with extremely high concentra-
tions of NE (1034 M) for a prolonged period of time
(48^72 h) reduced TNF-K production [38]. This ap-
pears to be mediated by a mechanism involving L2-
adrenoceptors signaling [38]. At the transcriptional
level, K2-adrenergic agonists increase TNF-K
mRNA accumulation, which can be blocked by an
K2-adrenergic antagonist, YHB [13]. Since the stim-
ulation of Kup¡er cell TNF-K production by NE can
be inhibited by the speci¢c K2-adrenergic antagonist
YHB, it appears that NE upregulation of TNF-K
production is mediated by an K2-adrenoceptor path-
way. A second mechanism by which TNF-K may be
upregulated by NE is the K2-adrenoceptor-mediated
calcium £ux into the cell resulting in increased intra-
cellular calcium (Ca2) levels [30]. Studies have dem-
onstrated that an increase in macrophage Ca2 plays
an important role in upregulating TNF-K production
[39,40]. Therefore, the blockade of Ca2 in£ux by
calcium channel blockers may be an e¡ective ap-
proach for attenuating the increased release of this
in£ammatory cytokine from Kup¡er cells due to NE
stimulation.
The central nervous system regulates systemic in-
£ammatory responses to sepsis through humoral
mechanisms. The stress-induced alterations in brain
activity lead to activation of brain-controlled out£ow
pathways to the periphery, such as the hypothalamo^
pituitary^adrenal axis and sympathetic nervous sys-
tem [41]. In contrast to the e¡ect of NE on TNF-K
production, a recent report indicated that the cho-
linergic parasympathetic nervous system modulates
the systemic in£ammatory response and reduces
TNF-K production in vivo by e¡erent vagus nerve
signaling [42]. Vagotomy signi¢cantly increased
TNF-K synthesis in liver and upregulated serum lev-
els of TNF-K. In vitro macrophage culture showed
that acetylcholine (ACh) inhibited TNF-K release
dose-dependently when stimulated by endotoxin
[42]. It remains to be determined whether the para-
sympathetic system is depressed during sepsis, which
upregulates TNF-K production.
In summary, our results indicate that administra-
tion of NE at a concentration which is similar to that
observed during early sepsis, upregulates TNF-K
production. It appears that this e¡ect is mediated
by the activation of K2-adrenoceptors. Thus, this
study provides further insight into the mechanism
responsible for the upregulation of TNF-K by gut-
derived NE during early sepsis as well as other path-
ophysiologic conditions such as trauma, hemorrhagic
shock, or gut ischemia/reperfusion. Since TNF-K
plays a major role in producing hepatocellular de-
pression following the onset of sepsis, modulation
of Kup¡er cell K2-adrenoceptor response to gut-de-
rived NE by K2-adrenergic antagonists may be a use-
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ful approach for attenuating cell and organ dysfunc-
tion during sepsis.
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